Home › T-Cell Lymphoma › California › Los Angeles
T-Cell Lymphoma clinical trials in Los Angeles, CA
3 studies for T-Cell Lymphoma are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of Southern California, Los Angeles
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- Cedars-Sinai Medical Center, Los Angeles
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's Hospital Los Angeles, Los Angeles
T-Cell Lymphoma trials in other cities
- New York City, NY13 studies
- Philadelphia, PA10 studies
- Baldwin Park, CA9 studies
- Boston, MA9 studies
- Houston, TX8 studies
- Atlanta, GA8 studies
- Rochester, MN6 studies
- Columbus, OH6 studies
- Chicago, IL6 studies
- Seattle, WA6 studies
- Miami, FL5 studies
- New Haven, CT5 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.